Vanguard DAMP/VanGuard DA2MP, 25x1 ml tray
formerly known as Vanguard DA2MP now will be labeled as Vanguard DAMP. Canine Distemper-Adenovirus Type 2-Measles-Parainfluenza Vaccine Modified Live Virus Description: Vanguard DAMP contains highly attenuated strains of CD virus measles virus CAV-2 and CPI virus propagated on an established canine cell line and freeze-dried to preserve stability. Contains penicillin and streptomycin as preservatives. Indications: Vanguard DAMP is for vaccination of healthy dogs 6 to 12 weeks of age as an aid in preventing canine distemper caused by canine distemper (CD) virus infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1) respiratory disease caused by canine adenovirus type 2 (CAV-2) and canine parainfluenza caused by canine parainfluenza (CPI) virus. Directions:
1. General Directions: Vaccination of healthy dogs 6 to 12 weeks of age is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided shake well and administer 1 mL intramuscularly. 2. Primary Vaccination: Administer a single 1-mL dose to healthy dogs between 6 and 12 weeks of age. 3. Revaccination: Dogs should be revaccinated at 14 to 16 weeks of age with a canine distemper canine adenovirus type 2 and canine parainfluenza vaccine. In most cases a complete immunization program will also include vaccination for canine parvovirus Leptospira canicola and L. icterohaemorrhagiae. At the discretion of the veterinarian annual revaccination with a single dose against any or all of these pathogens is recommended. Precaution(s):
Store at 2-7C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents. Caution(s): Vaccination of pregnant bitches should be avoided.As with many vaccines anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease are malnourished or parasitized are stressed due to shipment or environmental conditions are otherwise immunocompromised or the vaccine is not administered in accordance with label directions. Warning(s): For use in dogs only.
Presentation: Cartons of 25 x 1 dose vials.